Literature DB >> 723966

The intestine as source of immunoreactive substance P in plasma of the cat.

R Gamse, E Mroz, S Leeman, F Lembeck.   

Abstract

1. Substance P (SP) was measured in acid acetone extracted plasma of cats using a sensitive radioimmunoassay. The immunoreactive material was submitted to ion exchange chromatography and at least 90% of immunoreactivity co-chromatographed with synthetic SP. 2. The level of immunoreactive SP (I-SP) in extracted plasma of the cat was 69.3 +/- 9.8 fmol/ml with values ranging from 2.5 to 165 fmol/ml. Evisceration of the cats caused a decrease of I-SP levels from 70.8 +/- 30.8 fmol/ml to 20.8 +/- 9.9 15 min and to 26.8 +/- 19.7 fmol/ml 60 min after the operation. 3. Ligation of intestinal blood vessels led to a fall in I-SP levels from 58.7 +/- 11.5 to 25.9 +/- 4.1 fmol/ml within 15 min. 4. No difference between I-SP values in portal (71.8 +/- 11.2 fmol/ml) and peripheral plasma (68.3 +/- 12.1 fmol/ml) was found under the conditions in which these experiments were performed. 5. It is concluded that a major part of circulating immunoreactive SP originates from the intestine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 723966     DOI: 10.1007/bf00497001

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat.

Authors:  M Otsuka; S Konishi
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

2.  Circulating immunoreactive substance P in man.

Authors:  P Skrabanek; D Cannon; J Kirrane; D Legge; D Powell
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

3.  Release of substance P-like immunoreactivity from the dental pulp.

Authors:  L Olgart; B Gazelius; E Brodin; G Nilsson
Journal:  Acta Physiol Scand       Date:  1977-12

4.  Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P.

Authors:  M M Chang; S E Leeman
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

5.  Localization of substance P-like immunoreactivity in mouse gut.

Authors:  G Nilsson; L I Larsson; R Håkanson; E Brodin; B Pernow; F Sundler
Journal:  Histochemistry       Date:  1975

6.  Enterochromaffin cells as the endocrine source of gastrointestinal substance P.

Authors:  P Heitz; J M Polak; D M Timson; A G Pearse
Journal:  Histochemistry       Date:  1976-11-12

7.  Substance P secretion by carcinoid tumours.

Authors:  P Skrabanek; D Cannon; J Kirrane; D Powell
Journal:  Ir J Med Sci       Date:  1978-02       Impact factor: 1.568

8.  Elimination of substance P from the circulation of the rat and its inhibition by bacitracin.

Authors:  F Lembeck; P Holzer; M Schweditsch; R Gamse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

9.  Substance P radioimmunoassay using Nalpha-tyrosyl-substance P and demonstration of the presence of substance P-like immunoreactivities in human blood and porcine tissue extracts.

Authors:  C Yanaihara; H Sato; M Hirohashi; M Sakagami; K Yamamoto
Journal:  Endocrinol Jpn       Date:  1976-12

10.  Substance P in the vagus nerve. Immunochemical and immunohistochemical evidence for axoplasmic transport.

Authors:  R Gamse; F Lembeck; A C Cuello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

View more
  5 in total

1.  Substance P-containing nerve fibres in large peripheral blood vessels of the rat.

Authors:  F Barja; R Mathison; H Huggel
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

2.  Elimination of substance P from the circulation of the rat and its inhibition by bacitracin.

Authors:  F Lembeck; P Holzer; M Schweditsch; R Gamse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

3.  Difference in behaviour between synthetic and endogenous substance P in human plasma.

Authors:  D E Cannon; P Skrabanek; D Powell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds.

Authors:  P G Withrington
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.